Most-read stories on, January 2023

COURTESY RHODE ISLAND HOSPITAL 1. Lifespan announces ‘breakthrough’ in brain cancer research POSTED ONLINE: JAN. 6. Lifespan Cancer Institute researchers said the phase 3 trial of the DCVax-L vaccine showed improved survival rates in patients with newly diagnosed and returning glioblastoma, the most common and most lethal form of brain cancer.   2.…

You must be a paid subscriber to read this content. To keep reading and receive unlimited access subscribe today for only $1.
Subscribe Now Already a Subscriber? Login now

Purchase NowWant to share this story? Click Here to purchase a link that allows anyone to read it on any device whether or not they are a subscriber.